An error occurred retrieving content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
At one year, intravitreal aflibercept improved visual acuity more than panretinal photocoagulation, costing £5475 more in total resource use.
1 National Institute for Health Research Clinical Research Facility, Moorfields Biomedical Research Centre, London, UK
2 University College London Institute of Ophthalmology, London, UK
3 Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK
4 King’s Clinical Trials Unit King’s College London, London, UK
5 Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK
6 Department of Diabetes and Endocrinology, King’s College Hospital NHS Foundation Trust, London, UK
* Corresponding author Email: Sobha.sivaprasad@moorfields.nhs.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.